Menopause is the day 12 months after your last period; the years that follow are post-menopause. Most of what is medically important happens in those years: cardiovascular risk rises, bone loss accelerates, the genitourinary syndrome of menopause develops, and the symptom burden of the perimenopausal years either resolves or carries forward. Modern hormone therapy, particularly when started during or close to the menopausal transition, is safe and effective for most women under 60 and meaningfully reduces both symptom burden and downstream bone loss. Fishtown Medicine treats menopause as the start of a 30-year health arc rather than an inconvenience to ride out.
The clinical mistake we see most often in menopause care in Philadelphia is treating it as a discrete event to ride out, rather than as the start of a 30-year health arc. Patients are told the hot flashes will pass, the sleep will settle, and life will return to normal. For some women it does; for many, the symptoms continue. And for almost everyone, the underlying biology - bone, cardiovascular, metabolic, genitourinary - keeps changing in ways that deserve a full plan for the years ahead, well beyond easing symptoms as they come.
This page is how we approach menopause at Fishtown Medicine in Philadelphia: the workup, the hormone therapy conversation in 2026 terms, and the longer arc most practices do not have time to build.
What menopause is, clinically
Menopause is officially the day 12 months after your last menstrual period, in the absence of pregnancy or other cause. Everything before that, going back as far as the cycles started to change, is perimenopause. Everything after is post-menopause.
The average age of menopause in the United States is 51, but there is a wide range. Surgical menopause (oophorectomy) and chemotherapy-induced menopause behave differently because the hormonal drop is sudden rather than gradual.
The symptoms that most people associate with menopause - hot flashes, night sweats, sleep disruption, mood changes, brain fog, joint pain, vaginal dryness, libido changes - usually start in perimenopause and either resolve or persist into the post-menopausal years. About 80% of women experience significant vasomotor symptoms (hot flashes and night sweats); for about a third, those symptoms persist for more than a decade.
What changes in the post-menopausal body
The clinically important changes happen in the years after the last period rather than on the day itself. The big ones:
- Cardiovascular risk moves upward. Pre-menopausal women have substantially lower cardiovascular disease risk than men of the same age. That gap closes in the years after menopause, and by the 60s and 70s, women and men have similar cardiovascular event rates. Most of that shift comes from the loss of estrogen.
- Bone loss accelerates. The fastest rate of bone loss happens in the year before and the few years after menopause. Without intervention, many women lose 10-20% of their bone density in this window. This is the bone density future osteoporotic fractures are built from.
- The genitourinary syndrome of menopause develops. Vaginal dryness, urinary frequency and urgency, increased UTI risk, dyspareunia. This affects most women to some degree and is one of the most reliably treatable symptom clusters in all of medicine.
- Body composition changes. Loss of lean mass, central weight gain that did not used to happen at the same caloric intake, and changes in insulin sensitivity.
- Sleep architecture changes. Even after vasomotor symptoms settle, the underlying sleep quality often remains different.
- Cognitive changes. The brain fog of perimenopause often resolves; the long-term cognitive trajectory is the question, and the evidence on hormone therapy's effect there is still developing.
What modern hormone therapy looks like
The 2022 NAMS position statement is the current best summary of the evidence. The reading:
- For most healthy women under 60 (or within 10 years of menopause) with bothersome symptoms, hormone therapy is appropriate. The cardiovascular risk profile is favorable in this window, the bone benefit is well established, and the symptom relief is meaningful.
- The form matters. Transdermal estradiol (patch, gel) avoids the thromboembolism risk of oral estrogen. For women with a uterus, micronized progesterone is the preferred progestogen.
- Vaginal estrogen for genitourinary symptoms is essentially free of systemic risk and works extraordinarily well. It is underused by an order of magnitude relative to need.
- The "5-year maximum" rule has been retired. Duration stays an open conversation rather than a hard cutoff.
- The risk profile is different after age 60 or 10+ years after menopause. Starting hormone therapy fresh in this window carries different risks; continuing therapy that started earlier is usually fine.
For women without a uterus, estrogen alone is the standard.
How menopause care works at Fishtown Medicine
Fishtown Medicine
A 90-minute conversation with Dr. Ash. A written plan you can actually follow.
A new patient's first visit is 90 minutes. The history is most of the work: cycle history, age at menopause if reached, symptom inventory, family history of breast cancer, blood clots, osteoporosis, dementia, current medications, current contraception or hormone therapy.
Labs we typically run:
- TSH and free T4 (thyroid disease overlaps heavily).
- Comprehensive metabolic panel, fasting lipid panel with ApoB.
- HbA1c and fasting insulin.
- Vitamin D, B12.
- CBC.
- Hormone panel (FSH, estradiol) for confirmation when needed.
- Bone density (DEXA) baseline for most women in or after the menopausal transition.
Beyond labs, we build a plan around: hormone therapy decision (if appropriate), bone health (strength training, calcium, vitamin D, DEXA at baseline and serial), cardiovascular risk management (ApoB targets, blood pressure, lipids), sleep, training, alcohol, and a full screening cadence (mammograms, colon cancer screening, age-appropriate cardiovascular).
We follow up at 4-6 weeks after starting any new therapy, and then at 3-6 month intervals.
What it costs
Membership at Fishtown Medicine covers all visits and ongoing management; see pricing for current rates. All visits and direct messaging access are covered. Hormone therapy prescriptions (transdermal estradiol, micronized progesterone, vaginal estrogen) are typically inexpensive at most Philadelphia pharmacies with cash or insurance pricing. Labs and DEXA scans are billed separately at the cheapest of insurance or cash.
Key Takeaways
- Menopause is one day; the post-menopausal years are where the long-arc decisions happen.
- Cardiovascular risk moves upward, bone loss accelerates, and the genitourinary syndrome develops.
- Modern hormone therapy started during or near the transition is safe and effective for most women under 60.
- Vaginal estrogen for genitourinary symptoms is essentially risk-free and dramatically underused.
- Fishtown Medicine builds the 30-year plan rather than stopping at symptom triage.
Related Services and Reading
-
Perimenopause Care in Philadelphia - the 4-10 years before menopause.
-
Hormone Optimization in Philadelphia - the broader hormones framing.
-
Menopause 3.0 - the long-form modern menopause guide.
-
Women's Hormone Health Pillar - the umbrella framing.
-
DEXA Scan in Philadelphia - bone density and body composition.
-
Direct Primary Care in Philadelphia - how membership covers this.
-
TRT (Testosterone Replacement Therapy) - the safe, monitored TRT approach
-
Thyroid Treatment - thyroid optimization beyond TSH alone
-
PCOS Care - the metabolic and hormonal management of PCOS
-
Menopause Weight Gain and GLP-1s - how GLP-1 medications fit after the transition without costing you muscle and bone
-
Testosterone for Women - the one evidence-backed use, with the limits stated plainly
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.
